← FDA Drug Approvals (Drugs@FDA)

ISENTRESS

NDA · New Drug Application · Sponsor: MSD SUB MERCK · Approved 2011-12-21

Drug application

FDA Application #

NDA203045

Application type

New Drug Application

Brand name

ISENTRESS

Generic name

RALTEGRAVIR

Active ingredients

RALTEGRAVIR POTASSIUM

Dosage form

TABLET, CHEWABLE

Route

ORAL

Marketing status

Prescription

Sponsor

MSD SUB MERCK

Manufacturer

Merck Sharp & Dohme LLC

First approval

2011-12-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown